Afatinib
Product Specifications
Background
Afatinib is a clinically useful kinase inhibitor approved for the treatment of non-small cell lung cancer. It is a potent and highly selective inhibitor of mutant and wild-type EGFR (IC50 = 0.5 nM) and HER2 (IC50 = 14 nM) .
Conjugation
Unconjugated
Buffer
Pale yellow solid
Storage Conditions
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
M1201-52-APC 100 µL
Macrophage Derived Chemokine (MDC) (APC) discontinued
Sign In for Pricing
View Details 
OKAG01395 96 Well
DCLK2 Colorimetric Cell-Based ELISA Kit (OKAG01395)
Sign In for Pricing
View Details